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yocardial Scars More Frequent Than Expected
agnetic Resonance Imaging Detects Potential Risk Group
harlotte Ebeling Barbier, MD,* Tomas Bjerner, MD, PHD,* Lars Johansson, PHD,*†
ars Lind, MD, PHD,†‡ Håkan Ahlström, MD, PHD*
ppsala and Gothenburg, Sweden
OBJECTIVES The aim of this study was to investigate the prevalence of clinically recognized myocardial
infarctions (RMIs) and unrecognized myocardial infarctions (UMIs) in 70-year-old subjects,
assessed with magnetic resonance imaging (MRI), and to relate the findings to cardiac
function and morbidity.
BACKGROUND Late enhancement MRI identifies myocardial scars and thereby has the potential to
detect UMI.
METHODS Cardiac MRI was performed on 259 randomly chosen 70-year-old subjects. Late enhance-
ment and cine sequences were acquired, and the ejection fraction and left ventricular (LV)
mass were calculated. Late enhancement involving the subendocardial layer was considered to
represent myocardial infarction (MI) scars, and their volumes were calculated. Information on
cardiac morbidity and risk factors was collected from medical records and from a health
examination. Subjects with MI scars, with or without a hospital diagnosis of MI were
classified as RMI or UMI, respectively.
RESULTS The images from 248 subjects (123 women, 125 men) were assessable. Myocardial infarction
scars were found in 60 subjects (24.2%), in 49 of whom (19.8%) they were UMIs. The
volumes of the UMIs were significantly smaller than those of the RMIs. There was an
increased frequency of chest pain symptoms among the subjects with UMI or RMI compared
with those without MI scars. Ejection fraction was significantly lower and LV mass
significantly larger in the subjects with UMI or RMI than in those without MI scars.
CONCLUSIONS Unrecognized MI detected with MRI was more frequent than expected in 70-year-old
subjects. The subjects displaying these UMIs may represent a previously unknown potential
risk group for future cardiovascular events. (J Am Coll Cardiol 2006;48:765–71) © 2006 by
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.05.041the American College of Cardiology Foundation
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(ntil recently, the primary tool for estimating the preva-
ence and prognosis of clinically unrecognized myocardial
nfarction (UMI) has been detection of Q waves on elec-
rocardiography (ECG) (1,2). Using this method, UMI has
een estimated to constitute at least one-fourth of all
yocardial infarctions (MIs) (1,2), and the prevalence is
aid to increase with age, approximately 10% per year (3).
he true prevalence of UMI, however, remains unknown,
ecause not all MIs result in persistent Q waves (4).
Unrecognized MI, with persistent Q waves, signifies a
onsiderable health risk, as indicated by the fact that affected
ersons have risk factor profiles and mortality rates similar
o those in persons with recognized myocardial infarction
RMI) (2).
Myocardial enhancement that is present on magnetic
esonance imaging (MRI) when the intravascular concen-
ration of gadolinium contrast is declining is referred to as
ate enhancement. Late enhancement MRI accurately de-
From the *Department of Radiology, Uppsala University Hospital, Uppsala,
weden; †AstraZeneca, Gothenburg, Sweden; and the ‡Department of Medicine,
ppsala University Hospital, Uppsala, Sweden. Supported by the Swedish Research
ouncil, grant no. K2003-71X-06676-21A and The Linné Foundation for Medical
esearch, Uppsala, Sweden. GE Healthcare provided contrast agent. Drs. Johansson
nd Lind are employed by AstraZeneca.n
Manuscript received March 3, 2006; revised manuscript received April 7, 2006,
ccepted April 17, 2006.ects MIs and other myocardial scars as hyperintense areas
5–7). As late enhancement MRI detects not only Q-wave
Is but also non–Q-wave MIs (7), this technique may
eveal an even greater prevalence of UMI than has previ-
usly been estimated. The aim of this study was to investi-
ate the prevalence of RMI and UMI in a population-based
ample of 70-year-old subjects, assessed with MRI, and to
elate the findings to cardiac function and morbidity.
ETHODS
tudy population. After approval from the ethical com-
ittee, cardiac MRI was performed on an unselected
ubsample from the PIVUS (Prospective Investigation of
he Vasculature in Uppsala Seniors) study (8).
Eligible for the PIVUS study were all subjects aged 70
ears and resident in the municipality of Uppsala, Sweden.
he subjects were chosen in a randomized manner from the
egister of municipality inhabitants, and 2,025 subjects were
nvited to participate within weeks from their 70th birthday;
,016 agreed and gave written informed consent (Fig. 1).
From the original cohort, 283 subjects were consecutively
nvited to undergo cardiac MRI, which was finally per-
ormed on 259 subjects, with a mean delay of 16 months
range 3 to 22 months) from the primary investigations. The
umber of subjects invited was determined by the availabil-
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hat the interval between the primary investigations and the
RI examination should not be too long. Eleven examina-
ions were not assessable because of poor quality, leaving
ssessable data from 248 subjects (123 women, 125 men)
Fig. 1).
The basic characteristics and major cardiovascular risk fac-
ors among these subjects (Table 1) did not differ significantly
rom those in the entire PIVUS study population (8) except
hat there were fewer current smokers in the subjects of the
resent study (7.7% compared with 11%). The cardiac mor-
idity of the participants in the PIVUS study did not differ
rom that of the background population (8).
ubject data. Participants in the PIVUS study answered a
uestionnaire about their medical and drug histories. Fur-
hermore, medical records from Uppsala University Hospi-
al were searched retrospectively for cardiovascular diag-
oses. Of the 248 subjects with assessable late enhancement
RIs, 157 had been treated at the hospital, and their
Abbreviations and Acronyms
CHF  congestive heart failure
EF  ejection fraction
LV  left ventricle/ventricular
MI  myocardial infarction
MRA  magnetic resonance angiography
MRI  magnetic resonance imaging
PIVUS  Prospective Investigation of the Vasculature in
Uppsala Seniors study
RMI  recognized myocardial infarction
UMI  unrecognized myocardial infarction
igure 1. Groups were formed from the population-based sample of 70-ye
nfarction scar; RMI  recognized myocardial infarction (i.e., MI scar in com
yocardial infarction.edical records were scrutinized (C.E.B.). Two subjects
eported in the questionnaire that they had been treated for
Is at other hospitals. Their medical records were retrieved
nd studied (C.E.B.). Subjects with a hospital diagnosis of
I were considered to have had a clinical MI and are
ereafter referred to by that term. The hospital diagnosis of
I was set using the World Health Organization criteria
efore the year 2000 (n  4) and the criteria defined by the
oint European Society of Cardiology/American College of
ardiology Committee thereafter (n  7) (9).
subjects. MRI  magnetic resonance imaging; No MI  no myocardial
able 1. Basic Characteristics and Major Cardiovascular Risk
actors
Study Population (n  248)
Mean (SD)
emale gender, % 49.6
eight, cm 169 (9.1)
eight, kg 77 (13)
aist circumference, cm 91 (10)
ody mass index, kg/m2 26.9 (4.0)
aist/hip ratio 0.90 (0.065)
ystolic blood pressure, mm Hg 150 (22)
iastolic blood pressure, mm Hg 79 (9)
eart rate, beats/min 61 (8.6)
erum cholesterol, mmol/l 5.4 (0.94)
DL cholesterol, mmol/l 3.4 (0.83)
DL cholesterol, mmol/l 1.5 (0.37)
erum triglycerides, mmol/l 1.3 (0.65)
asting blood glucose, mmol/l 5.3 (1.5)
ypertension, % 73.0
ypercholesterolemia, % 54.4
iabetes, % 12.5
urrent smoking, % 7.7
DL  high-density lipoprotein; LDL  low-density lipoprotein.ar-old
bination with MI diagnosis in medical records); UMI  unrecognized
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August 15, 2006:765–71 Myocardial Scars More Frequent Than ExpectedSubjects lacking medical records and who did not report
I in the questionnaire were regarded as not having had a
linical MI (n  88). One subject reported having been
reated for an MI at Uppsala University Hospital, but had
o medical record there and was regarded as not having had
ny clinical MI.
In the PIVUS study, blood pressure, fasting blood glu-
ose, low-density lipoprotein cholesterol, and 12-lead ECG
ere measured using standard techniques (8). The following
efinitions were applied: hypertension  blood pressure
140/90 mm Hg or antihypertensive treatment; diabetes
asting blood glucose 6.2 mmol/l or antidiabetic treat-
ent; hypercholesterolemia  low-density lipoprotein cho-
esterol 3.5 mmol/l or lipid-lowering treatment; Q-wave
n ECG  Minnesota codes 1:1 or 1:2 (10).
The data on cardiac morbidity of the subjects (Table 2)
ere taken from the medical records. The term “other
ardiac diagnoses” includes atrial fibrillation, other arrhyth-
ias, congestive heart failure (CHF), and valvular disorders.
mage acquisition. Imaging was performed on a 1.5-T
RI system (Gyroscan Intera, Philips Medical Systems,
est, the Netherlands) with a 25 mT/m gradient system,
sing the standard SENSE cardiac coil (Philips Medical
ystems) in the supine position and retrospectively gated
ector ECG for cardiac triggering.
After injection of 40 ml Gd-DTPA-BMA (Omniscan,
E Healthcare, Oslo, Norway), the subjects were initially
ubmitted to whole body magnetic resonance angiography
MRA), after which late enhancement images were acquired
sing a 3-dimensional inversion recovery gradient echo
equence covering the entire heart in short- and long-axis
iews. The acquired slice thickness was 10 mm with a
esolution of 1.56  2.81 mm. The inversion time was
ndividually adjusted to null viable myocardium for every
ubject. The mean post-contrast time was 33.7 min, ranging
rom 25 to 64 min.
Cine images were acquired during breath holding using a
teady state free precession sequence covering the left
able 2. Cardiac Morbidity and Major Cardiovascular Risk Facto
No MI Scars
(n  188) No MI vs. UM
ardiac morbidity
Diagnosed angina 7 (3.7%) NS
Chest pain symptoms 25 (13.3%) *
Other cardiac diagnosis 12 (6.4%) *
PCI/CABG 3 (1.6%) NS
indings
Pathological ECG Q-wave 7 (3.7%) NS
isk factors
Hypertension 137 (72.9%) NS
Hypercholesterolemia 103 (54.8%) NS
Diabetes 19 (10.1%) NS
Current smoking 13 (6.9%) NS
p  0.0167, i.e., 0.05 with Bonferroni correction.
CABG coronary artery bypass graft surgery; MI myocardial infarction; No MI no
nfarction, i.e., MI scar in combination with MI diagnosis in medical records; UMI  unentricular (LV) myocardium from the apex to the atria in
-mm-thick short-axis slices with a 2.5-mm slice gap, an
cquired in-plane resolution of 2.27  1.81 mm, and 18
hases recorded per cardiac cycle. Two slices were acquired
er breath hold. The temporal resolution varied between the
ubjects depending on their heart rates.
mage analysis. For assessment of the late enhancement
mages, a PACS workstation (Impax, Agfa, Mortsel, Bel-
ium) was used by 2 observers (C.E.B. and T.B.) indepen-
ently and in a consensus reading. The observers were
linded to information on any previous disease.
Left ventricular myocardium nulled by the inversion pulse
as visually assessed as viable, whereas LV myocardium
howing late enhancement (i.e., hyperintense myocardium)
as classified as nonviable. To classify myocardium as
onviable, late enhancement had to be visible in short- as
ell as long-axis images, when long-axis images were
vailable (n 243 of 259). The areas showing late enhance-
ent were classified, by the same 2 observers in consensus,
nto 4 groups according to their distribution: transmural,
ubendocardial, located in the mitral valve insertion area, or
resenting another distribution. Late enhancement that
nvolved the subendocardial layer was considered to repre-
ent an MI scar (11,12) (Fig. 1) and is hereafter referred to
y that term.
The LV function was assessed (C.E.B.) on a workstation
ith commercially available analysis software. Quantifica-
ion was performed on short-axis images, using a semiau-
omatic method with papillary muscles included in the LV
ass. Ejection fraction (EF) and LV end-diastolic mass
ere computed assuming a myocardial density of 1.05 g/ml
13). The LV mass was adjusted for body surface area (14).
The myocardium displaying late enhancement was man-
ally outlined (C.E.B.). The volumes of the enhanced
yocardium were calculated in grams and in percent of the
V mass. The location of late enhancement was classified
C.E.B. and T.B. in consensus) in accordance with the
merican Heart Association segmentation (15).
Relation to Presence of MI Scars and Clinical MI
MI Scars (n  60)
RMI vs. No MI
UMI
(n  49)
UMI vs.
RMI
RMI
(n  11)
3 (6.1%) * 5 (45.5%) *
14 (28.6%) * 11 (100%) *
9 (18.3%) NS 2 (18.2%) *
2 (4.1%) * 7 (63.6%) *
3 (6.1%) * 5 (45.5%) *
35 (71.4%) NS 9 (81.8%) *
25 (51.0%) NS 7 (63.6%) *
8 (16.3%) NS 4 (36.4%) *
4 (8.2%) NS 2 (18.2%) NSrs in
IMI scar; PCI percutaneous coronary intervention; RMI recognized myocardial
recognized myocardial infarction.
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Myocardial Scars More Frequent Than Expected August 15, 2006:765–71Three groups were formed: subjects without MI scars (no
I); subjects with an MI scar but no clinical MI (i.e., a
MI); and subjects with both an MI scar and clinical MI
i.e., an RMI) (Fig. 1). The interobserver variability of the
ast consecutive 201 late enhancement assessments was
etermined.
The authors had full access to the data and take full
esponsibility for its integrity. All authors have read and
gree to the manuscript as written.
tatistical analysis. StatView 5.0.1 (SAS Institute, Cary,
orth Carolina) was used for statistical analyses. For esti-
ating differences between groups, the chi-square test and
onferroni correction were used. Analyses of variance of
nfarct size, EF, and LV mass were made using ANOVA,
ith Bonferroni correction for post-hoc analysis. The sig-
ificance level was set at 0.05 in all analyses.
ESULTS
ate enhancement was found in 72 (29%) of the 248
ubjects (Fig. 1). In 1 of these, only short-axis images were
vailable. In 39 of the 248 subjects (15.7%), the late
nhancement was transmural, in 21 (8.5%) it was subendo-
ardial, in 5 (2%) it was located mid-wall in the mitral
nsertion area, and in 7 (2.8%) it showed another distribu-
ion (4 mid-wall and 3 subepicardial).
Myocardial infarction scars were found in 60 of the 248
ubjects (24.2%) (Fig. 1); 24 of these were women and 36
ere men. None of the subjects displaying late enhancement
ad a diagnosis of myocarditis, sarcoidosis, amyloidosis, or
ilated or hypertrophic cardiomyopathy in their medical
ecords before MRI.
The subjects with RMI constituted 4.4% (11 of 248),
hereas 19.8% (49 of 248) had UMIs (Figs. 1 and 2). There
ere more women in the UMI group, 45% (n  22 of 49),
han in the group with RMIs, 18% (n  2 of 11). Two
ubjects (men) had clinical MI, but were not assessed as
igure 2. Short-axis magnetic resonance images from 10 consecutive subj
yocardial infarction scars were visible in the same location in both short and lon
he one displayed.aving any MI scar in the consensus reading. Three of the
9 subjects with UMI and 7 of the 188 without MI scars
ad a pathological Q-wave on ECG (Table 2). Unrecog-
ized MIs were more frequently located in the inferior and
nferolateral segments (15) of the LV, whereas RMIs
eemed to be more evenly distributed between the segments
Fig. 3).
The volumes of the UMIs were significantly smaller than
hose of the RMIs. Two subjects in the RMI group lacked cine
mages and, hence, a value of LV mass, and, therefore, the
olumes could not be calculated in percent for these 2 subjects.
he difference was significant, however, both when the vol-
mes were calculated in grams (UMI mean 2.5 g, range 0.11 to
1.7 g; RMI mean 9.3 g, range 0.20 to 26.9 g) and in percent
UMI mean 1.9% of LV mass, range 0.12% to 9.6%; RMI
ean 4.8% of LV mass, range 0.35% to 13.2%).
The cardiac morbidity and major cardiovascular risk
actors of the subjects without MI scars, with UMI, and
ith RMI are presented in Table 2. Cardiac morbidity was
ore frequent among the subjects with UMI or RMI than
n those without MI scars. Of the subjects with other
ardiac diagnoses in the UMI group, 1 had atrial fibrillation,
had other arrhythmias, 2 had CHF, and 2 had a valvular
isorder. In the RMI group, 1 had atrial fibrillation and 1
ad CHF. The UMI group and the RMI group did not
iffer in the frequency of these diagnoses (Table 2). The
revalence of hypertension, hypercholesterolemia, and dia-
etes was increased in the subjects with RMI compared with
hose without MI scars (Table 2).
Ejection fraction was significantly higher among the
ubjects without MI scars than among those with UMI or
MI (Fig. 4). Left ventricular mass was significantly larger
n the subjects with UMI than in those without MI scars
nd even larger in those with RMI (Fig. 4).
There was an interobserver agreement of 74% in the late
nhancement assessments. The agreement between observer
isplaying previously unrecognized myocardial infarctions. Note that theseects d
g axis and that some involve the subendocardial layer in another slice than
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nd consensus was 85%.
ISCUSSION
he present study revealed a greater prevalence of UMI
19.8%) than earlier estimates. The previous estimation tool
i.e., detection of Q waves on ECG) would only have
dentified 3 of the 49 UMIs that were detected with MRI
Table 2). Furthermore, 7 of the 188 subjects without MI
cars had pathological Q waves and would have been
lassified as having a UMI if ECG had been the tool,
roving a discrepancy in the use of the term UMI. However,
athological Q waves are known to occur in other condi-
ions than MIs (16–18), and not all MIs result in patho-
ogical Q waves (4), suggesting that ECG is a rather coarse
ool for detecting UMIs.
igure 3. The distribution of unrecognized (A) and recognized (B) myocard
egmentation.
igure 4. Differences in ejection fraction (EF) and in left ventricular (LV
ithout myocardial infarction scars (No MI), those with unrecognized myoca
RMI). *p  0.0167 (i.e., 0.05 with Bonferroni correction).In a previous study of 298 subjects, only 1 UMI was
ound with MRI (19). However, the investigated popu-
ation sample in that study consisted of corporation
mployees with a mean age of 50.2 years, where subjects
ith known MI, stroke, malignancy, or diabetes were
xcluded, and only 17% were women (19). The PIVUS
opulation can be regarded as representative of the
0-year-old Swedish population and so can the sample
nvestigated in the present study, since the basic charac-
eristics did not differ significantly (Table 1). However,
ecause the study sample was composed of 70-year-old
aucasians, the results cannot be generalized to other
thnic or age groups.
The subjects received a standardized gadolinium dose
uited for whole body MRA. Because cardiac MRI was
erformed after MRA, the post-contrast times were rather
ong. It has been claimed, however, that the best contrast
etween normal and enhanced myocardium in chronic MI
farction scars between the 17 segments of the American Heart Association
ss adjusted for body surface area (BSA) and gender between the subjects) ma
rdial infarction (UMI), and those with recognized myocardial infarction
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Myocardial Scars More Frequent Than Expected August 15, 2006:765–71s seen 25 to 30 min post-contrast (20). Furthermore, the
ubject imaged at 64 min post-contrast in the present study
resented very obvious enhancement.
Animal models have proved late enhancement MRI to be
n accurate method for detecting MIs and other myocardial
cars (5–7). The infarct size determined with MRI corre-
ates closely to triphenyltetrazolium chloride staining in
ogs (21,22), but no such studies have, to our knowledge,
een performed in humans. However, MRI infarct size of
cute MIs in humans correlates with other indexes of infarct
ize such as peak troponin I and EF (23).
Interpretation of late enhancement involving the suben-
ocardial layer as representing an MI scar is based on results
rom a study of 811 cardiac MRI examinations showing that
ate enhancement in ischemic infarction always involved
he subendocardial layer (11). This is supported by
ndings on comparison of MRI patterns in acute MI and
yocarditis (12).
Subendocardial late enhancement is not specific for MI.
t can also be present in myocarditis (12), sarcoidosis (11),
myloidosis (24), dilated cardiomyopathy (25), and hyper-
rophic cardiomyopathy (26). However, in the present
tudy, none of the subjects displaying late enhancement had
ny of those diagnoses in their medical records before the
RI examination. There is always a possibility that such a
isease might be undetected, but because ischemic disease is
ar more common, particularly in this age group, the late
nhancement is more likely to represent MI scars. This is
upported by the fact that only 1 UMI was found with MRI
n 298 subjects with a mean age of 50 years (19). Further-
ore, MI has proved to be one of the most frequently
issed clinical diagnoses, in comparisons with autopsy
ndings (27,28).
Women are said to present with atypical symptoms of MI
29,30), suggesting that their MIs would be unrecognized to
larger extent than MIs in men. In the present study, there
as also a larger proportion of women in the UMI group
45%) than in the group with RMI (18%). It has been
rgued that women get MIs later than men as a result of
rotective effects of sex hormones in fertile years (29), and
CG detects UMIs in the same proportion as RMIs in men
nd women (31). However, the prevalence data in the
resent study suggest that part of the difference may lie in
he recognition and not in the actual prevalence of MI.
The fact that the UMIs had significantly smaller volumes
han RMIs in this study can explain why UMIs escaped
linical recognition. These UMIs might have been too small
o cause any changes on ECG. In addition, MI can present
ithout chest pain and is then frequently unrecognized (32).
nly 28.6% of the subjects with UMI in the present study
ad come to the hospital with chest pain symptoms
Table 2). Furthermore, UMIs were frequently located in
he inferolateral segment, where ECG has lower sensitivity
han in the anterior and septal segments (4,33).
The clinical impact and prognosis of the UMIs detected
ith MRI is unknown. However, in the present study,everal findings indicate an increased risk in this group.
irst, cardiac morbidity was more common in subjects with
MI than in those without MI scars (and was even more
ommon in those with RMI) (Table 2), suggesting a
ossibly worse prognosis. The fact that there was no
ifference in the prevalence of revascularization between the
roup without MI scars and the UMI group, but a signif-
cant difference between both groups and the RMI group,
erely signifies that the RMI group is recognized and,
herefore, accessible for treatment. Second, the fact that EF
as significantly higher among subjects without MI scars
han among those with UMI or RMI indicates that cardiac
unction may be impaired in those with UMI as well as in
hose with RMI. Third, LV mass was significantly larger in
ubjects with UMI than in those without MI scars, and even
arger in those with RMI. These observations can endorse
he findings, because a larger myocardial mass needs more
xygen than a smaller one. A larger heart would, therefore,
e more vulnerable to an impaired blood supply due to
therosclerosis and would more likely become infarcted. A
arge LV mass is also associated with an increased preva-
ence of coronary atherosclerosis (34), MI, and a high
ortality risk (35–37).
It may be argued that infarctions as small as these UMIs
re not clinically relevant. However, the infarct size was
robably larger in the acute stage, because it decreases
uring healing (23,38,39). Furthermore, the fact that the
MI group differed from the group without MI scars in the
bove 3 parameters suggests a worse prognosis in this group
nd puts forward the importance of detecting these previ-
usly unrecognized MIs.
In conclusion, UMI detected with MRI was more fre-
uent than expected in 70-year-old subjects. The subjects
isplaying these UMIs may represent a previously unknown
otential risk group for future cardiovascular events. The
linical impact and prognosis of these UMIs need to be
stablished by further studies.
eprint requests and correspondence: Dr. Charlotte Ebeling
arbier, The Department of Radiology, Uppsala University Hos-
ital,75185Uppsala,Sweden.E-mail:Charlotte.Ebeling_Barbier@
adiol.uu.se.
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